T-CURX GMBH -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 8.728.185 253.750 1
2019 0 10.999.316 211.250 1
2018 0 6.097.875 503.750 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT3
BIOSCI CONSULTING BVBA2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE2
UNIVERSIDAD DE NAVARRA2
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ARTTIC1
ARTTIC INNOVATION1
ASTELLAS PHARMA EUROPE BV1
BAYER1
BLUEBIRD BIO INC1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
CELGENE MANAGEMENT SARL1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE1
COVANCE LABORATORIES1
DRKBLUTSPENDEDIENST BADENWURTTEMBERGHESSEN GGMBH1
DYNAMIC421
ERASMUS UNIVERSITEIT ROTTERDAM1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN HEMATOLOGY ASSOCIATION1
F HOFFMANNLA ROCHE1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
HOSPITAL CLINIC DE BARCELONA1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
INSTITUT DE RECHERCHES SERVIER1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT NATIONAL DU CANCER GIP1
JANSSEN PHARMACEUTICA NV1
JDRF INTERNATIONAL1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LUND UNIVERSITY1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MEDIZINISCHE UNIVERSITAET WIEN1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
MILTENYI BIOTEC BV & CO KG1
MYELOMA PATIENTS EUROPE AISBL1
NBETHERAPEUTICS1
NOVARTIS PHARMA1
OSPEDALE PEDIATRICO BAMBINO GESU1
OSPEDALE SAN RAFFAELE1
SANOFIAVENTIS1
STICHTING VUMC1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TECHNISCHE UNIVERSITAET MUENCHEN1
THE UNIVERSITY OF TUEBINGEN1
TRANSGENE1
UNIVERSITA VITASALUTE SAN RAFFAELE1
UNIVERSITAET LEIPZIG1
UNIVERSITAETSKLINIKUM JENA1
UNIVERSITE DU LUXEMBOURG1
UNIVERSITEIT TWENTE1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF OSLO1

Constancy:

Total number of partners: 65
Partner loyalty:
Frequent Partner: (> 2 projects): 6
Rare Partner: 59
Frequent / Rare Partner Ratio: 0.1

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2018-01-01SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease CARAMBAparticipant6.097.87511